Mental Health Clinics in Riverview, MI Accepting Medicare
6 Mental Health Clinics found. Showing 1 - 6
 Riverview Adult Day & Health Center Inc. Social Worker - Clinical Medicare: Not Enrolled in Medicare Practice Location: 18712 Quarry St, Riverview, MI 48193 Phone: 734-282-6070 Fax: 734-225-7355 |
Downriver Neurology Pc Psychiatry & Neurology - Neurology Medicare: Medicare Enrolled Practice Location: 17515 Fort St, Riverview, MI 48193 Phone: 734-225-7770 |
At Peace Guidance Services Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 16110 King Rd, Riverview, MI 48193 Phone: 734-365-6764 Fax: 734-621-6318 |
Achieve Counseling & Consulting Associates Plc Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 14600 King Rd, Riverview, MI 48193 Phone: 734-479-2708 Fax: 734-479-2736 |
Safe Haven Aba Llc Behavioral Analyst Medicare: Not Enrolled in Medicare Practice Location: 15622 Golfview Dr, Riverview, MI 48193 Phone: 734-493-2445 |
Touchstone Recovery Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 13249 Pennsylvania Rd, Riverview, MI 48193 Phone: 734-250-8056 |
News Archive
China's control measures during the first 50 days may have limited spread of COVID-19
China's control measures during the first 50 days of the COVID-19 epidemic may have delayed the spread of the virus to cities outside of Wuhan by several days and, by interrupting transmission nationwide, prevented more than 700,000 infections across the country, according to an international team of researchers.
Trubion Pharmaceuticals to present promising data from Phase 1 studies of SBI-087, SBI-087
Trubion Pharmaceuticals, Inc. today announced the acceptance of two Phase 1 data presentations on SBI-087 (PF-05230895) at the 2010 annual congress of the European League Against Rheumatism (EULAR) in Rome, Italy. Presentations will include promising data from a Phase 1 study of SBI-087 for the treatment of rheumatoid arthritis (RA) and a Phase 1 study of SBI-087 for the treatment of systemic lupus erythematosus (SLE). Copies of both abstracts are available at http://www.eular.org. SBI-087 is Trubion's next-generation CD20-directed small modular immunopharmaceutical (SMIP™) product candidate and is being developed in collaboration with Pfizer.
New positive data on Generex Oral-lyn published in Diabetes, Obesity and Metabolism
Generex Biotechnology Corporation announced today that the peer-reviewed scientific journal Diabetes, Obesity and Metabolism has published new positive data in respect of Generex Oral-lyn™, the Company's proprietary buccal insulin spray product.
HPV16 ctDNA assay predicts treatment response in metastatic head and neck cancer
Oncotarget published "Human papilloma virus circulating tumor DNA assay predicts treatment response in recurrent/metastatic head and neck squamous cell carcinoma" which reported that despite the rising incidence of human papillomavirus related oropharyngeal squamous cell carcinoma, treatment of metastatic disease remains palliative.
Cancer Commons researchers publish MDMM paper in PLoS ONE journal
Cancer Commons, an initiative of CollabRx, a provider of information technology to personalize cancer treatments and accelerate research, announces the publication of a molecular disease model of melanoma which classifies the disease into molecular subtypes, rather than traditional histological or cellular subtypes, and describes treatment guidelines for each subtype, including specific assays, drugs, and clinical trials.
› Verified 7 days ago